NIH Budget Tracks Doubling Goal

No one expects the events of Sept. 11-and the subsequent drains on the U.S. Treasury's surplus-to keep Congress from keeping its promise made in 1998 to double the National Institutes of Health budget by 2003. The proposed $22 billion-plus appropriation for Fiscal Year 2002 is close to the ensuing year's expected amount of about $26 billion. Congressional committee changes to President George W. Bush's NIH request prior to Sept. 11 have remained untouched. But the monies that Congress wants to

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

But the monies that Congress wants to spend on bioterrorism research and other security measures will come from the treasury's surplus, recently projected to drop from $237 billion to $127 billion. "Clearly," says Melissa Merson, communications director for the Congressional Budget Office, "a substantial amount of the surplus is being consumed. It's not unlikely that we will end up with a deficit for 2002."

So the question-and some say it's rhetorical-that could be asked is: what will happen after the NIH budget is doubled? Will the increases continue to keep pace with the commitments that the NIH has made to its grant recipients, in the face of a near-certain recession and surplus-less treasury? According to Bill Burton, spokesman for Sen. Tom Harkin, (D-Iowa) chairman of the Labor, Health and Human Services, and Education appropriations subcommittee, right now, Harkin is focused on the 2002 allotment. "Where the 2003 numbers come from, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Christine Bahls

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours